Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Praxis Precision Medicines (PRAX) Shares Outstanding (2022 - 2025)

Praxis Precision Medicines has reported Shares Outstanding over the past 4 years, most recently at $25.2 million for Q4 2025.

  • Quarterly results put Shares Outstanding at $25.2 million for Q4 2025, up 29.72% from a year ago — trailing twelve months through Dec 2025 was $25.2 million (up 29.72% YoY), and the annual figure for FY2025 was $25.2 million, up 29.72%.
  • Shares Outstanding for Q4 2025 was $25.2 million at Praxis Precision Medicines, up from $21.2 million in the prior quarter.
  • Over the last five years, Shares Outstanding for PRAX hit a ceiling of $25.2 million in Q4 2025 and a floor of $3.0 million in Q1 2022.
  • Median Shares Outstanding over the past 4 years was $11.0 million (2023), compared with a mean of $12.4 million.
  • Biggest five-year swings in Shares Outstanding: soared 243.11% in 2024 and later grew 18.5% in 2025.
  • Praxis Precision Medicines' Shares Outstanding stood at $3.3 million in 2022, then surged by 167.05% to $8.8 million in 2023, then surged by 120.91% to $19.4 million in 2024, then rose by 29.72% to $25.2 million in 2025.
  • The last three reported values for Shares Outstanding were $25.2 million (Q4 2025), $21.2 million (Q3 2025), and $21.0 million (Q2 2025) per Business Quant data.